An MRAS, SHOC2, and SCRIB Complex Coordinates ERK Pathway Activation with Polarity and Tumorigenic Growth

被引:93
|
作者
Young, Lucy C. [1 ]
Hartig, Nicole [1 ]
Munoz-Alegre, Marta [1 ]
Oses-Prieto, Juan A. [2 ]
Durdu, Sevi [3 ]
Bender, Sabine [1 ]
Vijayakumar, Vineetha [4 ]
Rudan, Matteo Vietri [1 ]
Gewinner, Christina [1 ]
Henderson, Stephen [1 ]
Jathoul, Amit P. [1 ]
Ghatrora, Rupinder [5 ,6 ]
Lythgoe, Mark F. [5 ,6 ]
Burlingame, Alma L. [2 ]
Rodriguez-Viciana, Pablo [1 ]
机构
[1] UCL, UCL Canc Inst, London WC1E 6BT, England
[2] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA
[3] European Mol Biol Lab, D-69117 Heidelberg, Germany
[4] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England
[5] UCL, UCL Ctr Adv Biomed Imaging, Div Med, London WC1E 6BT, England
[6] UCL, Inst Child Hlth, London WC1E 6BT, England
关键词
RICH REPEAT PROTEIN; CELL POLARITY; MESENCHYMAL TRANSITION; M-RAS; CANCER; PHOSPHATASE-1; FAMILY; EXPRESSION; MIGRATION; EFFECTOR;
D O I
10.1016/j.molcel.2013.10.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
SHOC2 is mutated in Noonan syndrome and plays a key role in the activation of the ERK-MAPK pathway, which is upregulated in the majority of human cancers. SHOC2 functions as a PP1-regulatory protein and as an effector of MRAS. Here we show that SHOC2 and MRAS form a complex with SCRIB, a polarity protein with tumor suppressor properties. SCRIB functions as a PP1-regulatory protein and antagonizes SHOC2-mediated RAF dephosphorylation through a mechanism involving competition for PP1 molecules within the same macromolecular complex. SHOC2 function is selectively required for the malignant properties of tumor cells with mutant RAS, and both MRAS and SHOC2 play a key role in polarized migration. We propose that MRAS, through its ability to recruit a complex with paradoxical components, coordinates ERK pathway spatiotemporal dynamics with polarity and that this complex plays a key role during tumorigenic growth.
引用
收藏
页码:679 / 692
页数:14
相关论文
共 44 条
  • [31] Epidermal growth factor and transforming growth factor-β1 enhance HK-2 cell migration through a synergistic increase of matrix metalloproteinase and sustained activation of ERK signaling pathway
    Tian, Ya-Chung
    Chen, Yung-Chang
    Chang, Chiz-Tzung
    Hung, Cheng-Chieh
    Wu, Mai-Szu
    Phillips, Aled
    Yang, Chih-Wei
    EXPERIMENTAL CELL RESEARCH, 2007, 313 (11) : 2367 - 2377
  • [32] Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications
    Fourneaux, Benjamin
    Chaire, Vanessa
    Lucchesi, Carlo
    Karanian, Marie
    Pineau, Raphael
    Laroche-Clary, Audrey
    Italiano, Antoine
    ONCOTARGET, 2017, 8 (05) : 7878 - 7890
  • [33] Octahedral Pt(IV) complex K101 induces apoptosis via ERK1/2 activation and the p53 pathway in human colon cancer cells
    Kwon, Young-Ee
    Kim, Kuk-Hwan
    ANTI-CANCER DRUGS, 2006, 17 (05) : 553 - 558
  • [34] Gain-Of-Function E76K-Mutant SHP2 Promotes Cell Proliferation, Metastasis, And Tumor Growth In Glioblastoma Through Activation Of The ERK/CREB Pathway
    Yang, Fan
    Xu, Mo
    Wang, Shiqing
    Song, Le
    Yu, Dandan
    Li, Yao
    Cao, Rui
    Xiong, Zhang
    Chen, Zhijun
    Zhang, Qian
    Zhao, Bing
    Wang, Siying
    ONCOTARGETS AND THERAPY, 2019, 12 : 9435 - 9447
  • [35] Angiopoietin-related growth factor enhances blood flow via activation of the ERK1/2-eNOS-NO pathway in a mouse hind-limb ischemia model
    Urano, Takashi
    Ito, Yasuhiro
    Akao, Masaki
    Sawa, Tomohiro
    Miyata, Keishi
    Tabata, Mitsuhisa
    Morisada, Tohru
    Hato, Tai
    Yano, Masato
    Kadomatsu, Tsuyoshi
    Yasunaga, Kunio
    Shibata, Rei
    Murohara, Toyoaki
    Akaike, Takaaki
    Tanihara, Hidenobu
    Suda, Toshio
    Oike, Yuichi
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (05) : 827 - 834
  • [36] Insulin-like growth factor binding protein-related protein 1 (IGFBPrP1) contributes to liver inflammation and fibrosis via activation of the ERK1/2 pathway
    Yarong Guo
    Yun Zhang
    Qianqian Zhang
    Xiaohong Guo
    Haiyan Zhang
    Guoping Zheng
    Lixin Liu
    Hepatology International, 2015, 9 : 130 - 141
  • [37] Insulin-like growth factor binding protein-related protein 1 (IGFBPrP1) contributes to liver inflammation and fibrosis via activation of the ERK1/2 pathway
    Guo, Yarong
    Zhang, Yun
    Zhang, Qianqian
    Guo, Xiaohong
    Zhang, Haiyan
    Zheng, Guoping
    Liu, Lixin
    HEPATOLOGY INTERNATIONAL, 2015, 9 (01) : 130 - 141
  • [38] Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway
    Sun, Xuerong
    Shi, Benyan
    Zheng, Huiling
    Min, Ling
    Yang, Jie
    Li, Xiaoyi
    Liao, Xiaoxin
    Huang, Weixing
    Zhang, Mingmeng
    Xu, Shun
    Zhu, Zhe
    Cui, Hongjing
    Liu, Xinguang
    CELL DEATH & DISEASE, 2018, 9
  • [39] ONCOSTATIN-M STIMULATES TYROSINE PROTEIN-PHOSPHORYLATION IN PARALLEL WITH THE ACTIVATION OF P42(MAPK)/ERK-2 IN KAPOSI CELLS - EVIDENCE THAT THIS PATHWAY IS IMPORTANT IN KAPOSI CELL-GROWTH
    AMARAL, MC
    MILES, S
    KUMAR, G
    NEL, AE
    JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (02): : 848 - 857
  • [40] Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway
    Xuerong Sun
    Benyan Shi
    Huiling Zheng
    Ling Min
    Jie Yang
    Xiaoyi Li
    Xiaoxin Liao
    Weixing Huang
    Mingmeng Zhang
    Shun Xu
    Zhe Zhu
    Hongjing Cui
    Xinguang Liu
    Cell Death & Disease, 9